Objective: To determine the prognostic utility of tauopathy-associated single nucleotide polymorphisms (SNPs) in sporadic behavioral-variant frontotemporal dementia (bvFTD).Methods: Eighty-one patients with sporadic bvFTD were genotyped for tauopathy-associated SNPs at rs8070723 (microtubule-associated protein tau [MAPT]) and rs1768208 (myelin-associated oligodendrocyte basic protein [MOBP]). We performed a retrospective case-control study comparing age at onset and disease duration between carriers of $1 polymorphism allele and noncarriers for these SNPs. Subanalyses were performed for autopsied subgroups with tauopathy (n 5 20) and TDP-43 proteinopathy (n 5 12). To identify a potential biological basis for disease duration, neuroimaging measures of white matter integrity were evaluated (n 5 37).Results: Carriers of risk allele (T) in rs1768208 (i.e., MOBP RA1) had a shorter median disease duration (TC/TT 5 5.5 years, CC 5 9.5 years; p 5 0.02). This was also found in the subset of cases with autopsy-confirmed tauopathies (p 5 0.04) but not with TDP-43 proteinopathies (p . 0.1). By comparison, polymorphisms at rs8070723 (MAPT) had no effect on disease duration (p . 0.1), although carriers of protective allele (G) in rs8070723 had a younger median age at onset (AG/GG 5 54.5 years, AA 5 58 years; p , 0.01). MOBP RA1 patients had increased radial diffusivity in the superior corona radiata and midbrain, and reduced fractional anisotropy in the superior corona radiata as well as superior and inferior longitudinal fasciculi compared with noncarriers (p , 0.01).
Conclusions:The rs1768208 risk polymorphism in MOBP may have prognostic value in bvFTD.MOBP RA1 patients have more severe white matter degeneration in bvFTD that may contribute to shorter disease duration. Future studies are needed to help confirm these findings. Neurology ® 2014;83:502-509 GLOSSARY AD 5 Alzheimer disease; ALS 5 amyotrophic lateral sclerosis; bvFTD 5 behavioral-variant frontotemporal dementia; FA 5 fractional anisotropy; FTD 5 frontotemporal dementia; FTLD 5 frontotemporal lobar degeneration; GM 5 gray matter; GMD 5 gray matter density; ILF 5 inferior longitudinal fasciculus; MAPT 5 microtubule-associated protein tau; MOBP 5 myelin-associated oligodendrocyte basic protein; PA 5 protective allele; PSP 5 progressive supranuclear palsy; RA 5 risk allele; RD 5 radial diffusion; SCR 5 superior corona radiata; SLF 5 superior longitudinal fasciculus; SNP 5 single nucleotide polymorphism; STG 5 superior temporal gyrus; TDP-43 5 TAR DNA-binding protein 43; WM 5 white matter.Significant heterogeneity exists in the natural history of behavioral-variant frontotemporal dementia (bvFTD), the most common clinical phenotype in frontotemporal lobar degeneration (FTLD) spectrum pathology. Approximately equal numbers of cases appear to be attributable to the 2 main broad categories of proteinopathies 1,2 : those containing pathologic aggregations of the microtubule-associated protein, tau (i.e., FTLD-tau), 3 and those with inclusions composed of the RNA-b...